In an independent population of lymph node-negative invasive breast cancer patients who did not receive adjuvant chemotherapy, we demonstrate that MGI+HOXB13:IL17BR and BCI are associated with risk of breast cancer death among ER-positive patients treated and untreated with tamoxifen. The gene discussed is IL17RB; the disease is breast carcinoma.